MYCOPHENOLATE MOFETIL HYDROCHLORIDE

MYCOPHENOLATE MOFETIL HYDROCHLORIDE was reported 138802 times

MYCOPHENOLATE MOFETIL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SMOOTH MUSCLE CELL NEOPLASM 296 0.7081
1 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1505 0.6418
2 TRICHODYSPLASIA SPINULOSA 243 0.6378
3 RENAL GRAFT INFECTION 145 0.6250
4 TRANSPLANT DYSFUNCTION 1069 0.5985
5 GRIP STRENGTH 135 0.5895
6 MALACOPLAKIA 263 0.5742
7 POLYOMAVIRUS VIRAEMIA 596 0.5612
8 CHRONIC ALLOGRAFT NEPHROPATHY 436 0.5568
9 DELAYED GRAFT FUNCTION 394 0.5541
10 C-REACTIVE PROTEIN 510 0.5502
11 HEART TRANSPLANT REJECTION 560 0.5395
12 PHAEOHYPHOMYCOSIS 257 0.5365
13 MYCOBACTERIUM HAEMOPHILUM INFECTION 149 0.5210
14 TRANSPLANT REJECTION 4170 0.5200
15 SWOLLEN JOINT COUNT 127 0.5080
16 DEEP VEIN THROMBOSIS POSTOPERATIVE 991 0.4948
17 PARVOVIRUS B19 INFECTION 434 0.4849
18 COMPLICATIONS OF TRANSPLANTED HEART 100 0.4651
19 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2343 0.4599
20 COMPLICATIONS OF TRANSPLANTED KIDNEY 1041 0.4586
21 HUMAN POLYOMAVIRUS INFECTION 243 0.4576
22 ALTERNARIA INFECTION 170 0.4570
23 LUPUS VULGARIS 563 0.4468
24 BK VIRUS INFECTION 1497 0.4434
25 RENAL TRANSPLANT FAILURE 431 0.4362
26 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 390 0.4212
27 GRAFT LOSS 296 0.4083
28 COMPLICATIONS OF TRANSPLANTED LUNG 124 0.4039
29 GRAFT DYSFUNCTION 114 0.4000
30 KIDNEY TRANSPLANT REJECTION 1912 0.3981
31 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 551 0.3900
32 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1073 0.3878
33 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 277 0.3853
34 PULMONARY MUCORMYCOSIS 203 0.3845
35 LUNG TRANSPLANT REJECTION 252 0.3818
36 MICROTIA 120 0.3810
37 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 113 0.3792
38 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 138 0.3791
39 SWOLLEN JOINT COUNT INCREASED 1200 0.3759
40 HUMAN HERPESVIRUS 8 INFECTION 228 0.3744
41 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 791 0.3714
42 CYSTITIS VIRAL 142 0.3708
43 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 242 0.3623
44 CYTOMEGALOVIRUS VIRAEMIA 1586 0.3562
45 CRYPTOSPORIDIOSIS INFECTION 185 0.3524
46 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 126 0.3471
47 VIRAL HAEMORRHAGIC CYSTITIS 240 0.3371
48 GRAFT VERSUS HOST DISEASE IN SKIN 739 0.3351
49 CYTOMEGALOVIRUS INFECTION REACTIVATION 1480 0.3347
50 EPSTEIN-BARR VIRAEMIA 368 0.3318
51 RETINITIS 568 0.3285
52 ADENOVIRUS INFECTION 949 0.3269
53 CYTOMEGALOVIRUS OESOPHAGITIS 120 0.3261
54 CHRONIC GRAFT VERSUS HOST DISEASE 1174 0.3248
55 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 673 0.3245
56 LYMPHOCELE 215 0.3238
57 ACUTE GRAFT VERSUS HOST DISEASE 1476 0.3221
58 GRAFT VERSUS HOST DISEASE IN LUNG 153 0.3201
59 LIVER TRANSPLANT REJECTION 568 0.3159
60 PULMONARY NOCARDIOSIS 259 0.3143
61 TRANSPLANT FAILURE 770 0.3138
62 CEREBRAL TOXOPLASMOSIS 292 0.3126
63 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1027 0.3106
64 RHEUMATIC FEVER 1345 0.3014
65 CYTOMEGALOVIRUS INFECTION 5007 0.3010
66 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 361 0.3008
67 MICROSPORIDIA INFECTION 104 0.2963
68 RENAL TUBULAR ATROPHY 256 0.2902
69 BLASTOMYCOSIS 140 0.2881
70 DISSEMINATED CRYPTOCOCCOSIS 217 0.2867
71 GRAFT VERSUS HOST DISEASE IN LIVER 204 0.2849
72 DISSEMINATED MUCORMYCOSIS 111 0.2817
73 CYTOMEGALOVIRUS ENTERITIS 100 0.2809
74 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 166 0.2809
75 LUPUS NEPHRITIS 516 0.2756
76 FACET JOINT SYNDROME 890 0.2731
77 CAT SCRATCH DISEASE 107 0.2662
78 EPSTEIN-BARR VIRUS INFECTION 1661 0.2656
79 DISLOCATION OF VERTEBRA 602 0.2637
80 CYTOMEGALOVIRUS COLITIS 603 0.2619
81 SCEDOSPORIUM INFECTION 183 0.2592
82 VARICELLA ZOSTER VIRUS INFECTION 531 0.2559
83 INFECTION REACTIVATION 293 0.2559
84 X-RAY ABNORMAL 458 0.2559
85 WEST NILE VIRAL INFECTION 190 0.2533
86 UREAPLASMA INFECTION 102 0.2500
87 HUMAN HERPESVIRUS 6 INFECTION 468 0.2474
88 TOXOPLASMOSIS 266 0.2463
89 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 426 0.2408
90 PNEUMONIA CYTOMEGALOVIRAL 467 0.2402
91 OVERLAP SYNDROME 167 0.2386
92 JC VIRUS INFECTION 378 0.2362
93 MUCORMYCOSIS 608 0.2338
94 NOCARDIOSIS 597 0.2332
95 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 360 0.2246
96 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 293 0.2225
97 RENAL TUBULAR INJURY 270 0.2222
98 CRYPTOCOCCOSIS 361 0.2213
99 VIRAEMIA 305 0.2201
100 HISTOPLASMOSIS DISSEMINATED 348 0.2191
101 RHEUMATOID FACTOR POSITIVE 1253 0.2167
102 STRONGYLOIDIASIS 347 0.2146
103 GRAFT COMPLICATION 123 0.2095
104 MENINGITIS CRYPTOCOCCAL 351 0.2006
105 DUODENAL ULCER PERFORATION 1493 0.2006
106 GRAFT VERSUS HOST DISEASE 1443 0.2005
107 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 104 0.1985
108 INFECTION IN AN IMMUNOCOMPROMISED HOST 141 0.1964
109 HEPATITIS E 310 0.1962
110 STENOTROPHOMONAS INFECTION 265 0.1953
111 CYTOMEGALOVIRUS TEST POSITIVE 345 0.1934
112 CENTRAL NERVOUS SYSTEM LYMPHOMA 266 0.1929
113 KIDNEY FIBROSIS 332 0.1912
114 C-REACTIVE PROTEIN ABNORMAL 1194 0.1860
115 ENCEPHALITIS VIRAL 225 0.1847
116 PNEUMOCYSTIS JIROVECII INFECTION 219 0.1833
117 THROMBOTIC MICROANGIOPATHY 1751 0.1795
118 EPSTEIN-BARR VIRUS TEST POSITIVE 112 0.1775
119 SYSTEMIC MYCOSIS 205 0.1755
120 CYSTITIS HAEMORRHAGIC 700 0.1735
121 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1117 0.1718
122 OBLITERATIVE BRONCHIOLITIS 225 0.1714
123 ALVEOLAR PROTEINOSIS 101 0.1706
124 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 138 0.1697
125 ASPERGILLUS INFECTION 1110 0.1689
126 URETERIC STENOSIS 135 0.1685
127 KLEBSIELLA INFECTION 849 0.1677
128 ENGRAFTMENT SYNDROME 98 0.1658
129 SERONEGATIVE ARTHRITIS 188 0.1640
130 PORPHYRIA ACUTE 235 0.1638
131 MYCOBACTERIUM CHELONAE INFECTION 119 0.1610
132 BONE EROSION 568 0.1605
133 MYCOPLASMA INFECTION 125 0.1601
134 BRAIN ABSCESS 403 0.1591
135 ACINETOBACTER INFECTION 172 0.1571
136 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1119 0.1560
137 FUSARIUM INFECTION 105 0.1500
138 ENTEROCOCCAL INFECTION 725 0.1499
139 VISCERAL LEISHMANIASIS 108 0.1496
140 MUSCLE INJURY 1222 0.1473
141 HELICOBACTER INFECTION 1507 0.1465
142 MYCOBACTERIUM ABSCESSUS INFECTION 104 0.1455
143 CYTOMEGALOVIRUS CHORIORETINITIS 283 0.1450
144 KLEBSIELLA BACTERAEMIA 137 0.1442
145 MYCOBACTERIAL INFECTION 248 0.1439
146 ENTEROCOCCAL BACTERAEMIA 152 0.1434
147 APLASIA PURE RED CELL 482 0.1400
148 HISTOPLASMOSIS 246 0.1388
149 FOLLICULITIS 1446 0.1378
150 PNEUMONIA CRYPTOCOCCAL 129 0.1365
151 VACCINATION FAILURE 227 0.1364
152 BRONCHOPULMONARY ASPERGILLOSIS 1045 0.1346
153 PERIPHERAL VENOUS DISEASE 550 0.1345
154 HERPES ZOSTER DISSEMINATED 108 0.1345
155 PEMPHIGUS 1592 0.1272
156 PNEUMOCYSTIS JIROVECII PNEUMONIA 1271 0.1265
157 GASTROENTERITIS NOROVIRUS 168 0.1264
158 SUPERINFECTION BACTERIAL 100 0.1261
159 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 99 0.1256
160 ENTEROBACTER INFECTION 211 0.1254
161 URINARY TRACT INFECTION ENTEROCOCCAL 114 0.1221
162 LIP DRY 1088 0.1197
163 STEROID DEPENDENCE 104 0.1185
164 HAND DEFORMITY 1538 0.1171
165 ENTEROVIRUS INFECTION 99 0.1146
166 PSEUDOMONAS INFECTION 983 0.1145
167 BLOOD PRESSURE DIASTOLIC ABNORMAL 291 0.1143
168 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1091 0.1142
169 AUTOIMMUNE DISORDER 1111 0.1139
170 IGA NEPHROPATHY 189 0.1139
171 ANOGENITAL WARTS 100 0.1121
172 PNEUMONIA KLEBSIELLA 206 0.1120
173 STEROID DIABETES 166 0.1106
174 GLOMERULONEPHRITIS 267 0.1090
175 HYPOGAMMAGLOBULINAEMIA 715 0.1087
176 HAEMOLYTIC URAEMIC SYNDROME 250 0.1078
177 BREAST CANCER STAGE III 693 0.1069
178 BLOOD IRON ABNORMAL 104 0.1064
179 AMAUROSIS FUGAX 114 0.1058
180 PNEUMATOSIS INTESTINALIS 299 0.1047
181 NOROVIRUS INFECTION 149 0.1032
182 BACTERIAL SEPSIS 336 0.1031
183 WOUND INFECTION 1129 0.1030
184 VENOOCCLUSIVE LIVER DISEASE 508 0.1028
185 ATYPICAL MYCOBACTERIAL INFECTION 145 0.1025
186 SYSTEMIC CANDIDA 257 0.1023
187 SCIATICA 1630 0.1021
188 GINGIVAL HYPERTROPHY 155 0.1021
189 KLEBSIELLA SEPSIS 115 0.1020
190 PAPILLOMA VIRAL INFECTION 168 0.1018
191 JOINT RANGE OF MOTION DECREASED 1354 0.1009
192 ASPERGILLOSIS 131 0.1002
193 ESCHERICHIA INFECTION 816 0.0991
194 ACUTE MYELOID LEUKAEMIA RECURRENT 210 0.0977
195 PYELONEPHRITIS ACUTE 191 0.0973
196 CUSHINGOID 308 0.0959
197 VENOOCCLUSIVE DISEASE 238 0.0950
198 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 711 0.0946
199 LYMPHOPROLIFERATIVE DISORDER 276 0.0939
200 DIFFUSE LARGE B-CELL LYMPHOMA 720 0.0933
201 NEPHROPATHY TOXIC 1045 0.0930
202 ACTINIC KERATOSIS 240 0.0924
203 SYNOVITIS 1663 0.0921
204 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 244 0.0917
205 CENTRAL NERVOUS SYSTEM INFECTION 105 0.0916
206 DRUG TOLERANCE DECREASED 253 0.0900
207 RENAL ARTERY STENOSIS 124 0.0899
208 BLOOD PRESSURE SYSTOLIC ABNORMAL 220 0.0889
209 PNEUMONIA PSEUDOMONAL 132 0.0860
210 FUNGAEMIA 135 0.0857
211 HERPES SIMPLEX 555 0.0853
212 PERICARDITIS 1427 0.0848
213 PARAINFLUENZAE VIRUS INFECTION 129 0.0847
214 PNEUMONIA FUNGAL 330 0.0836
215 TRANSITIONAL CELL CARCINOMA 108 0.0832
216 DISSEMINATED TUBERCULOSIS 213 0.0829
217 BILE DUCT STENOSIS 98 0.0817
218 NEPHROTIC SYNDROME 555 0.0809
219 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2203 0.0777
220 SQUAMOUS CELL CARCINOMA OF SKIN 458 0.0758
221 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 624 0.0756
222 GRIP STRENGTH DECREASED 664 0.0754
223 ENCEPHALITIS AUTOIMMUNE 99 0.0753
224 HYPERCHOLESTEROLAEMIA 724 0.0749
225 SOFT TISSUE INFECTION 137 0.0748
226 NORMOCYTIC ANAEMIA 109 0.0741
227 MATERNAL EXPOSURE TIMING UNSPECIFIED 278 0.0739
228 LIVE BIRTH 617 0.0737
229 URINARY TRACT INFECTION BACTERIAL 186 0.0735
230 ESCHERICHIA BACTERAEMIA 172 0.0731
231 RENAL TUBULAR NECROSIS 708 0.0721
232 OPPORTUNISTIC INFECTION 130 0.0702
233 SCLERODERMA 255 0.0701
234 FUNGAL SKIN INFECTION 283 0.0700
235 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 138 0.0698
236 SYSTEMIC LUPUS ERYTHEMATOSUS 2474 0.0696
237 BACTERAEMIA 814 0.0685
238 GLOSSODYNIA 1524 0.0680
239 INFECTIOUS PLEURAL EFFUSION 103 0.0676
240 ESCHERICHIA SEPSIS 196 0.0676
241 PNEUMOMEDIASTINUM 122 0.0674
242 RED BLOOD CELL SEDIMENTATION RATE INCREASED 741 0.0669
243 DERMATOMYOSITIS 167 0.0659
244 IRRITABLE BOWEL SYNDROME 1412 0.0658
245 STAPHYLOCOCCAL BACTERAEMIA 286 0.0657
246 BURSITIS 798 0.0657
247 FIBROMYALGIA 1568 0.0644
248 ACUTE RESPIRATORY DISTRESS SYNDROME 1137 0.0642
249 RENAL TUBULAR ACIDOSIS 140 0.0641
250 VARICELLA 153 0.0640
251 RHINOVIRUS INFECTION 244 0.0626
252 PYELONEPHRITIS 539 0.0621
253 COVID-19 PNEUMONIA 734 0.0621
254 LOWER LIMB FRACTURE 1192 0.0620
255 ESCHERICHIA URINARY TRACT INFECTION 263 0.0618
256 PULMONARY FIBROSIS 1183 0.0616
257 PROTEINURIA 1166 0.0613
258 RENAL TRANSPLANT 217 0.0600
259 ORGANISING PNEUMONIA 294 0.0593
260 MYCOBACTERIUM AVIUM COMPLEX INFECTION 157 0.0584
261 PNEUMONIA BACTERIAL 521 0.0567
262 WOUND 1578 0.0564
263 SEPTIC SHOCK 2449 0.0562
264 HISTIOCYTOSIS HAEMATOPHAGIC 167 0.0562
265 LIVER INJURY 1366 0.0556
266 PNEUMOPERITONEUM 102 0.0552
267 LUPUS-LIKE SYNDROME 500 0.0551
268 RENAL TUBULAR DISORDER 153 0.0543
269 EXOSTOSIS 486 0.0532
270 AUTOIMMUNE HAEMOLYTIC ANAEMIA 182 0.0530
271 PRESCRIBED OVERDOSE 1026 0.0530
272 PNEUMONIA VIRAL 168 0.0526
273 LUNG ABSCESS 110 0.0524
274 LIVER ABSCESS 170 0.0524
275 EMPYEMA 104 0.0523
276 ENCEPHALITIS 355 0.0513
277 HAEMATOLOGICAL INFECTION 125 0.0511
278 IMPAIRED HEALING 1658 0.0504
279 HYDRONEPHROSIS 378 0.0504
280 TYPE 2 DIABETES MELLITUS 1638 0.0486
281 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 242 0.0485
282 WALKING AID USER 320 0.0485
283 LEUKOPENIA 2427 0.0485
284 WOUND DEHISCENCE 163 0.0482
285 LYMPHOPENIA 677 0.0478
286 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 110 0.0477
287 NEPHROGENIC SYSTEMIC FIBROSIS 144 0.0476
288 B-CELL LYMPHOMA 161 0.0474
289 HEPATIC FIBROSIS 162 0.0472
290 FIBROSIS 145 0.0471
291 PATHOGEN RESISTANCE 429 0.0470
292 HEPATITIS B REACTIVATION 149 0.0469
293 OBESITY 747 0.0468
294 PULMONARY ALVEOLAR HAEMORRHAGE 263 0.0468
295 PULMONARY TUBERCULOSIS 200 0.0468
296 SERUM SICKNESS 129 0.0462
297 BRONCHIECTASIS 311 0.0461
298 CLOSTRIDIUM DIFFICILE COLITIS 488 0.0460
299 BLOOD IMMUNOGLOBULIN G DECREASED 114 0.0460
300 APLASTIC ANAEMIA 239 0.0457
301 THERAPY NON-RESPONDER 2038 0.0453
302 ENDOCARDITIS 232 0.0452
303 PSORIATIC ARTHROPATHY 1826 0.0449
304 ARTHRITIS BACTERIAL 183 0.0445
305 ABDOMINAL INFECTION 111 0.0434
306 PRESCRIBED UNDERDOSE 859 0.0430
307 SQUAMOUS CELL CARCINOMA 404 0.0429
308 MYASTHENIA GRAVIS 346 0.0428
309 DRUG LEVEL INCREASED 704 0.0425
310 GRANULOMA 146 0.0421
311 LUNG CONSOLIDATION 117 0.0418
312 STAPHYLOCOCCAL SEPSIS 206 0.0417
313 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 158 0.0413
314 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2255 0.0411
315 CANDIDA INFECTION 691 0.0409
316 OESOPHAGEAL CANDIDIASIS 163 0.0409
317 JOINT DISLOCATION 432 0.0408
318 GROWTH RETARDATION 120 0.0407
319 AGRANULOCYTOSIS 755 0.0406
320 OVARIAN CYST 406 0.0406
321 IMMUNOSUPPRESSION 354 0.0401
322 LARGE INTESTINAL ULCER 108 0.0397
323 HEPATOSPLENOMEGALY 102 0.0397
324 HEPATIC NECROSIS 149 0.0395
325 ENTERITIS 252 0.0393
326 IMMUNE THROMBOCYTOPENIA 180 0.0393
327 SKIN PAPILLOMA 157 0.0391
328 THERAPY PARTIAL RESPONDER 610 0.0391
329 HERPES VIRUS INFECTION 222 0.0385
330 UROSEPSIS 354 0.0383
331 LEUKOENCEPHALOPATHY 142 0.0381
332 MYOPATHY 329 0.0381
333 BACTERIAL INFECTION 709 0.0380
334 CHOLANGITIS 235 0.0379
335 OLIGURIA 235 0.0378
336 HYPERVOLAEMIA 187 0.0378
337 SUSPECTED OFF LABEL USE 169 0.0374
338 HEPATITIS C 451 0.0373
339 CYTOPENIA 455 0.0371
340 NECROTISING FASCIITIS 131 0.0371
341 TREATMENT FAILURE 3072 0.0370
342 HAEMODYNAMIC INSTABILITY 282 0.0370
343 POLYARTHRITIS 195 0.0370
344 SHOCK HAEMORRHAGIC 300 0.0368
345 OESOPHAGEAL STENOSIS 103 0.0362
346 BREAST CANCER STAGE II 301 0.0361
347 FOOT DEFORMITY 399 0.0360
348 SKIN HYPERTROPHY 101 0.0359
349 BRAIN HERNIATION 107 0.0358
350 NECROSIS 197 0.0354
351 GUILLAIN-BARRE SYNDROME 171 0.0353
352 DRUG RESISTANCE 906 0.0352
353 BLOOD CREATININE INCREASED 2291 0.0351
354 ULCER HAEMORRHAGE 237 0.0350
355 ENTEROCOLITIS 200 0.0346
356 RENAL CELL CARCINOMA 169 0.0345
357 RESPIRATORY FAILURE 2510 0.0344
358 HEPATIC CIRRHOSIS 646 0.0343
359 PANCYTOPENIA 1921 0.0343
360 INTENTIONAL PRODUCT USE ISSUE 2994 0.0341
361 HIP ARTHROPLASTY 518 0.0338
362 NORMOCHROMIC NORMOCYTIC ANAEMIA 101 0.0336
363 MYOSITIS 301 0.0335
364 NEPHRITIS 112 0.0335
365 HYPERTRANSAMINASAEMIA 233 0.0335
366 STAPHYLOCOCCAL INFECTION 1104 0.0334
367 OEDEMA 1812 0.0334
368 DYSLIPIDAEMIA 169 0.0332
369 GAIT INABILITY 1105 0.0330
370 ROAD TRAFFIC ACCIDENT 1379 0.0329
371 MUCOSAL INFLAMMATION 861 0.0329
372 ANURIA 281 0.0326
373 RENAL IMPAIRMENT 2741 0.0326
374 LUNG DISORDER 1594 0.0325
375 END STAGE RENAL DISEASE 593 0.0325
376 HEPATITIS B 195 0.0323
377 ENDOPHTHALMITIS 193 0.0321
378 OESOPHAGEAL ULCER 123 0.0320
379 LIVER TRANSPLANT 115 0.0316
380 ACUTE RESPIRATORY FAILURE 608 0.0316
381 LUNG INFILTRATION 279 0.0316
382 THROMBOTIC THROMBOCYTOPENIC PURPURA 111 0.0315
383 CONTRAINDICATED PRODUCT ADMINISTERED 952 0.0314
384 SEPSIS 3501 0.0314
385 NIGHT SWEATS 1008 0.0313
386 LIVER DISORDER 1386 0.0312
387 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 535 0.0312
388 DRUG LEVEL ABOVE THERAPEUTIC 142 0.0310
389 NEUROTOXICITY 543 0.0310
390 HYPERURICAEMIA 127 0.0309
391 HAEMOLYTIC ANAEMIA 276 0.0308
392 SPONDYLITIS 111 0.0305
393 HAEMODIALYSIS 256 0.0305
394 AUTOIMMUNE HEPATITIS 212 0.0305
395 LOWER RESPIRATORY TRACT INFECTION 1383 0.0304
396 MULTI-ORGAN FAILURE 521 0.0301
397 INFUSION RELATED REACTION 1996 0.0301
398 DISSEMINATED INTRAVASCULAR COAGULATION 422 0.0299
399 PRODUCT USE IN UNAPPROVED INDICATION 7426 0.0299
400 AZOTAEMIA 119 0.0298
401 TUBULOINTERSTITIAL NEPHRITIS 557 0.0297
402 PULMONARY FUNCTION TEST DECREASED 130 0.0297
403 DRUG INTOLERANCE 2863 0.0296
404 RALES 172 0.0296
405 GLUCOSE TOLERANCE IMPAIRED 175 0.0296
406 LEFT VENTRICULAR HYPERTROPHY 125 0.0292
407 ODYNOPHAGIA 173 0.0290
408 OSTEOARTHRITIS 1225 0.0289
409 URINARY TRACT DISORDER 130 0.0288
410 REBOUND EFFECT 325 0.0287
411 DISEASE RECURRENCE 1368 0.0287
412 ASCITES 844 0.0287
413 RESPIRATORY SYNCYTIAL VIRUS INFECTION 248 0.0285
414 C-REACTIVE PROTEIN INCREASED 1035 0.0284
415 CARDIAC TAMPONADE 135 0.0284
416 HYPERCALCAEMIA 350 0.0283
417 BLOOD PRESSURE DIASTOLIC INCREASED 130 0.0281
418 INFLAMMATION 1451 0.0281
419 CACHEXIA 144 0.0280
420 INFECTION 4015 0.0277
421 VASCULITIS 323 0.0277
422 BLOOD CHOLESTEROL INCREASED 1288 0.0276
423 PYODERMA GANGRENOSUM 99 0.0275
424 HEPATITIS CHOLESTATIC 165 0.0274
425 STOMATITIS 1661 0.0274
426 BASAL CELL CARCINOMA 427 0.0273
427 MENINGITIS 182 0.0272
428 HYPERAMMONAEMIA 135 0.0270
429 SUBCUTANEOUS ABSCESS 129 0.0269
430 HEPATIC ENZYME INCREASED 1831 0.0268
431 HEPATOCELLULAR CARCINOMA 204 0.0268
432 GENERALISED OEDEMA 332 0.0268
433 FUNGAL INFECTION 891 0.0267
434 BONE MARROW FAILURE 539 0.0265
435 MENINGITIS ASEPTIC 119 0.0265
436 POSTOPERATIVE WOUND INFECTION 179 0.0265
437 CANDIDIASIS 106 0.0264
438 PULMONARY HAEMORRHAGE 206 0.0263
439 HYPERBILIRUBINAEMIA 272 0.0262
440 SPLENOMEGALY 307 0.0262
441 ENCEPHALOPATHY 641 0.0261
442 SKIN NECROSIS 135 0.0260
443 ACUTE KIDNEY INJURY 3964 0.0259
444 UVEITIS 350 0.0258
445 WHEEZING 1520 0.0256
446 INTERSTITIAL LUNG DISEASE 1240 0.0256
447 GASTROINTESTINAL TOXICITY 123 0.0256
448 BLEPHAROSPASM 161 0.0255
449 URINE OUTPUT DECREASED 222 0.0254
450 OSTEOPOROSIS 1041 0.0253
451 DELIRIUM 875 0.0252
452 HYPOALBUMINAEMIA 195 0.0251
453 PNEUMONIA ASPIRATION 625 0.0250
454 GASTROINTESTINAL DISORDER 2234 0.0249
455 BLISTER 1399 0.0249
456 PROTEIN URINE PRESENT 124 0.0248
457 ARTHROPATHY 1374 0.0247
458 LARGE INTESTINE PERFORATION 171 0.0246
459 INTRACRANIAL PRESSURE INCREASED 137 0.0246
460 DRUG TOLERANCE 123 0.0243
461 NEPHROPATHY 227 0.0243
462 FAILURE TO THRIVE 126 0.0242
463 HYPERTRIGLYCERIDAEMIA 142 0.0242
464 LUNG INFECTION 376 0.0242
465 JOINT STIFFNESS 634 0.0241
466 SKIN INFECTION 269 0.0240
467 MUSCULOSKELETAL PAIN 1248 0.0238
468 PERICARDIAL EFFUSION 549 0.0237
469 HYPERKALAEMIA 832 0.0237
470 STREPTOCOCCAL INFECTION 132 0.0237
471 PREGNANCY 475 0.0237
472 BLOOD CREATINE INCREASED 105 0.0237
473 COLITIS 896 0.0236
474 GASTROENTERITIS 343 0.0235
475 TOXIC ENCEPHALOPATHY 119 0.0235
476 HAEMOLYSIS 180 0.0233
477 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 239 0.0233
478 OFF LABEL USE 20344 0.0232
479 CHOLESTASIS 445 0.0232
480 MOBILITY DECREASED 1662 0.0231
481 HYPERLIPIDAEMIA 275 0.0230
482 HYDROCEPHALUS 125 0.0229
483 HERPES ZOSTER 1318 0.0229
484 GLOMERULAR FILTRATION RATE DECREASED 281 0.0228
485 ACUTE HEPATIC FAILURE 308 0.0225
486 KNEE ARTHROPLASTY 468 0.0222
487 CARDIAC FAILURE ACUTE 148 0.0222
488 DRUG LEVEL DECREASED 226 0.0222
489 APHTHOUS ULCER 172 0.0222
490 MOUTH ULCERATION 467 0.0221
491 RASH VESICULAR 107 0.0221
492 HAEMATURIA 752 0.0219
493 ANGIOPATHY 123 0.0219
494 ILL-DEFINED DISORDER 1325 0.0218
495 ADRENAL INSUFFICIENCY 264 0.0217
496 BLOOD ALBUMIN DECREASED 171 0.0215
497 IMMUNODEFICIENCY 321 0.0215
498 ACIDOSIS 164 0.0214
499 DEVICE RELATED INFECTION 330 0.0214
500 METASTASES TO LYMPH NODES 144 0.0213
501 DRUG INTERACTION 3372 0.0212
502 PERITONITIS 439 0.0212
503 DRUG-INDUCED LIVER INJURY 665 0.0212
504 PULMONARY MASS 315 0.0211
505 BLOOD PRESSURE SYSTOLIC INCREASED 411 0.0211
506 INJURY 1480 0.0210
507 TYPE 1 DIABETES MELLITUS 126 0.0209
508 DISCOMFORT 1274 0.0209
509 SINUSITIS 2140 0.0209
510 HAEMORRHAGIC STROKE 163 0.0209
511 SKIN MASS 139 0.0208
512 THERAPEUTIC PRODUCT EFFECT DECREASED 929 0.0207
513 OESOPHAGITIS 226 0.0207
514 BLOOD PRESSURE DIASTOLIC DECREASED 152 0.0206
515 PLEURISY 122 0.0205
516 MYOCARDITIS 234 0.0204
517 HEPATOTOXICITY 453 0.0203
518 CLOSTRIDIUM DIFFICILE INFECTION 444 0.0203
519 MALABSORPTION 106 0.0203
520 ATELECTASIS 196 0.0203
521 EAR INFECTION 539 0.0202
522 COVID-19 3553 0.0202
523 SKIN LESION 555 0.0202
524 BRAIN OEDEMA 255 0.0202
525 HYPOVOLAEMIA 118 0.0201
526 RESPIRATORY DISTRESS 555 0.0201
527 HAEMATOTOXICITY 191 0.0201
528 MATERNAL EXPOSURE DURING PREGNANCY 1774 0.0199
529 MULTIPLE ALLERGIES 155 0.0198
530 NEUTROPENIA 2687 0.0197
531 RHEUMATOID ARTHRITIS 2243 0.0197
532 LIVER FUNCTION TEST INCREASED 417 0.0194
533 NORMAL NEWBORN 105 0.0193
534 HYPOXIA 679 0.0193
535 FEBRILE NEUTROPENIA 1276 0.0192
536 RESPIRATORY TRACT INFECTION 499 0.0191
537 UPPER RESPIRATORY TRACT INFECTION 884 0.0191
538 RESPIRATORY DISORDER 569 0.0190
539 ACUTE MYELOID LEUKAEMIA 296 0.0190
540 BLOOD UREA INCREASED 318 0.0190
541 NAIL DISORDER 166 0.0190
542 GASTROINTESTINAL INFECTION 170 0.0189
543 CARDIOGENIC SHOCK 271 0.0189
544 GENERAL PHYSICAL HEALTH DETERIORATION 2179 0.0188
545 THROMBOCYTOPENIA 2104 0.0188
546 ORAL DISORDER 137 0.0187
547 COAGULOPATHY 311 0.0186
548 MALNUTRITION 208 0.0186
549 PNEUMOTHORAX 294 0.0185
550 SWELLING 1735 0.0185
551 ABSCESS 295 0.0185
552 EAR PAIN 357 0.0183
553 TRANSAMINASES INCREASED 406 0.0182
554 METABOLIC ACIDOSIS 583 0.0182
555 NEUROLOGICAL SYMPTOM 104 0.0182
556 BLOOD BILIRUBIN INCREASED 491 0.0182
557 HEPATIC FAILURE 547 0.0181
558 PEMPHIGOID 136 0.0180
559 INTESTINAL ISCHAEMIA 99 0.0180
560 STATUS EPILEPTICUS 203 0.0180
561 DIARRHOEA HAEMORRHAGIC 168 0.0180
562 JOINT SWELLING 2161 0.0179
563 HEPATITIS 457 0.0178
564 OSTEOMYELITIS 322 0.0178
565 RENAL FAILURE CHRONIC 136 0.0177
566 PULMONARY HYPERTENSION 363 0.0174
567 MUSCULOSKELETAL STIFFNESS 1513 0.0173
568 SHOCK 397 0.0172
569 GASTRIC ULCER 327 0.0172
570 ORAL CANDIDIASIS 226 0.0171
571 HYPOMAGNESAEMIA 238 0.0171
572 PNEUMONIA 5519 0.0170
573 HAEMORRHAGE INTRACRANIAL 253 0.0169
574 SKIN ULCER 437 0.0169
575 PYREXIA 5839 0.0169
576 IRON DEFICIENCY ANAEMIA 155 0.0168
577 CORONAVIRUS INFECTION 111 0.0168
578 HYPERTENSION 3524 0.0166
579 DUODENAL ULCER 117 0.0166
580 JOINT EFFUSION 114 0.0165
581 VIRAL INFECTION 550 0.0165
582 COMA 786 0.0165
583 PLEURAL EFFUSION 1004 0.0165
584 BLOOD LACTATE DEHYDROGENASE INCREASED 261 0.0165
585 DRY MOUTH 1333 0.0164
586 DIABETES MELLITUS 1249 0.0164
587 PAPULE 115 0.0163
588 EXPOSURE DURING PREGNANCY 1012 0.0163
589 LIVER FUNCTION TEST ABNORMAL 473 0.0162
590 METASTASES TO LUNG 187 0.0162
591 NEUTROPENIC SEPSIS 114 0.0159
592 DYSPNOEA EXERTIONAL 598 0.0159
593 LEUKOCYTOSIS 287 0.0158
594 PANCREATITIS ACUTE 356 0.0158
595 HEPATOMEGALY 155 0.0158
596 SLEEP DISORDER 1111 0.0157
597 METASTASIS 112 0.0157
598 DIPLOPIA 407 0.0157
599 RENAL FAILURE 2052 0.0154
600 HEPATIC ENCEPHALOPATHY 144 0.0154
601 CONDITION AGGRAVATED 4653 0.0153
602 RIGHT VENTRICULAR FAILURE 107 0.0153
603 MITRAL VALVE INCOMPETENCE 172 0.0152
604 OSTEOPENIA 227 0.0149
605 RENAL FAILURE ACUTE 634 0.0149
606 HEMIPARESIS 252 0.0149
607 ARTERIOSCLEROSIS 140 0.0149
608 BLOOD PRESSURE FLUCTUATION 352 0.0147
609 DIALYSIS 208 0.0146
610 ANAEMIA 2790 0.0146
611 HYPOPHOSPHATAEMIA 108 0.0146
612 CONTUSION 1402 0.0145
613 PNEUMONITIS 396 0.0145
614 CELLULITIS 732 0.0145
615 URINARY TRACT INFECTION 2466 0.0144
616 PURPURA 127 0.0143
617 EPILEPSY 438 0.0143
618 MYELODYSPLASTIC SYNDROME 207 0.0143
619 PRODUCT PRESCRIBING ISSUE 311 0.0143
620 HAEMATOCRIT DECREASED 283 0.0143
621 EYELID PTOSIS 144 0.0142
622 HYPERGLYCAEMIA 516 0.0141
623 ULCER 225 0.0141
624 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 240 0.0141
625 ORAL HERPES 275 0.0141
626 SUBARACHNOID HAEMORRHAGE 143 0.0140
627 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 124 0.0140
628 ILEUS 174 0.0140
629 MALIGNANT MELANOMA 187 0.0139
630 DISABILITY 276 0.0139
631 ALTERED STATE OF CONSCIOUSNESS 302 0.0139
632 OSTEONECROSIS 457 0.0139
633 HEPATIC FUNCTION ABNORMAL 517 0.0138
634 DISEASE PROGRESSION 1633 0.0138
635 AMNESIA 896 0.0138
636 OEDEMA PERIPHERAL 1677 0.0137
637 LOW BIRTH WEIGHT BABY 109 0.0137
638 INFLAMMATORY BOWEL DISEASE 134 0.0137
639 MYOCLONUS 163 0.0137
640 HYPOAESTHESIA 2041 0.0136
641 VISUAL FIELD DEFECT 98 0.0135
642 LYMPHADENOPATHY 480 0.0135
643 TRICUSPID VALVE INCOMPETENCE 107 0.0135
644 MENTAL STATUS CHANGES 374 0.0135
645 INFUSION SITE PAIN 173 0.0134
646 HEPATOCELLULAR INJURY 189 0.0133
647 PULMONARY ARTERIAL HYPERTENSION 193 0.0133
648 LYMPHOMA 205 0.0133
649 OXYGEN SATURATION DECREASED 741 0.0132
650 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 386 0.0132
651 CENTRAL NERVOUS SYSTEM LESION 181 0.0132
652 PREMATURE DELIVERY 209 0.0131
653 TOXICITY TO VARIOUS AGENTS 2213 0.0131
654 FACIAL PARALYSIS 111 0.0130
655 SMALL INTESTINAL OBSTRUCTION 159 0.0129
656 MUSCULAR WEAKNESS 1460 0.0128
657 RESPIRATORY RATE INCREASED 114 0.0128
658 OPTIC NEURITIS 116 0.0128
659 BLOOD ALKALINE PHOSPHATASE INCREASED 316 0.0127
660 MUSCLE ATROPHY 161 0.0127
661 GAMMA-GLUTAMYLTRANSFERASE INCREASED 280 0.0126
662 PHOTOSENSITIVITY REACTION 208 0.0126
663 GENERALISED TONIC-CLONIC SEIZURE 208 0.0126
664 THERAPEUTIC RESPONSE DECREASED 758 0.0125
665 WEIGHT FLUCTUATION 130 0.0124
666 CARDIOMYOPATHY 183 0.0124
667 FLUID OVERLOAD 180 0.0124
668 FREQUENT BOWEL MOVEMENTS 333 0.0123
669 ABDOMINAL DISCOMFORT 2059 0.0123
670 BLINDNESS 499 0.0122
671 PANCREATITIS 645 0.0122
672 SKIN CANCER 258 0.0120
673 DIVERTICULITIS 331 0.0119
674 ALOPECIA 2343 0.0119
675 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 572 0.0119
676 GOUT 212 0.0118
677 CONFUSIONAL STATE 1899 0.0117
678 COLITIS ULCERATIVE 523 0.0117
679 WHITE BLOOD CELL COUNT INCREASED 441 0.0115
680 INTESTINAL PERFORATION 129 0.0115
681 WEIGHT INCREASED 2573 0.0115
682 PHOTOPHOBIA 214 0.0114
683 ARTHRITIS 895 0.0114
684 ALANINE AMINOTRANSFERASE INCREASED 693 0.0113
685 PULMONARY OEDEMA 504 0.0112
686 TACHYPNOEA 153 0.0112
687 TUMOUR LYSIS SYNDROME 99 0.0112
688 PERIPHERAL SWELLING 1730 0.0112
689 OCULAR DISCOMFORT 126 0.0112
690 ELECTROLYTE IMBALANCE 130 0.0112
691 CEREBRAL INFARCTION 273 0.0112
692 DIARRHOEA 7211 0.0112
693 CATARACT 663 0.0111
694 MYELOSUPPRESSION 399 0.0111
695 RENAL DISORDER 516 0.0111
696 NEOPLASM 127 0.0110
697 HAEMATOMA 285 0.0110
698 FLANK PAIN 103 0.0110
699 DYSPEPSIA 1077 0.0109
700 KIDNEY INFECTION 212 0.0108
701 TACHYCARDIA 959 0.0108
702 PRODUCTIVE COUGH 512 0.0107
703 DECREASED APPETITE 2490 0.0107
704 ATAXIA 127 0.0107
705 ASTHMA 1200 0.0106
706 GLAUCOMA 204 0.0106
707 DRUG TOXICITY 144 0.0106
708 TREATMENT NONCOMPLIANCE 577 0.0105
709 LABORATORY TEST ABNORMAL 309 0.0105
710 GASTRITIS 275 0.0104
711 CARDIOMEGALY 128 0.0104
712 HAEMOPTYSIS 289 0.0104
713 HEPATIC CYTOLYSIS 132 0.0103
714 NEUTROPHIL COUNT INCREASED 106 0.0103
715 DIABETIC KETOACIDOSIS 247 0.0103
716 WEIGHT DECREASED 2868 0.0103
717 SEASONAL ALLERGY 145 0.0102
718 HAEMOGLOBIN DECREASED 1050 0.0102
719 ABDOMINAL PAIN 2377 0.0102
720 ABORTION SPONTANEOUS 409 0.0102
721 NASOPHARYNGITIS 1880 0.0102
722 GASTROOESOPHAGEAL REFLUX DISEASE 819 0.0102
723 CHRONIC KIDNEY DISEASE 772 0.0102
724 CIRCULATORY COLLAPSE 173 0.0101
725 CARDIAC FAILURE 814 0.0101
726 CHEST PAIN 1870 0.0101
727 CYTOKINE RELEASE SYNDROME 202 0.0101
728 PRODUCT USE ISSUE 1876 0.0100
729 HYPONATRAEMIA 561 0.0099
730 MASS 139 0.0099
731 HYPERSENSITIVITY 1844 0.0099
732 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 706 0.0099
733 URTICARIA 1642 0.0098
734 POST PROCEDURAL COMPLICATION 188 0.0098
735 ASPIRATION 105 0.0096
736 PETECHIAE 100 0.0096
737 JAUNDICE 256 0.0095
738 BODY TEMPERATURE INCREASED 194 0.0095
739 HYPOCALCAEMIA 179 0.0094
740 CYSTITIS 300 0.0094
741 BLOOD POTASSIUM INCREASED 152 0.0094
742 CEREBRAL HAEMORRHAGE 334 0.0093
743 RECTAL HAEMORRHAGE 400 0.0093
744 MEDICATION ERROR 514 0.0092
745 INTRAOCULAR PRESSURE INCREASED 118 0.0092
746 HAEMATEMESIS 234 0.0092
747 HEAD DISCOMFORT 163 0.0092
748 POLYNEUROPATHY 110 0.0092
749 LYMPHOCYTE COUNT DECREASED 162 0.0092
750 NERVOUS SYSTEM DISORDER 286 0.0092
751 ASPARTATE AMINOTRANSFERASE INCREASED 485 0.0091
752 TASTE DISORDER 185 0.0091
753 HYPOKALAEMIA 418 0.0090
754 COUGH 2535 0.0090
755 BRONCHITIS 668 0.0090
756 FLUID RETENTION 459 0.0090
757 VOMITING 4236 0.0090
758 CARDIAC ARREST 743 0.0090
759 RASH MACULO-PAPULAR 198 0.0089
760 CHOLECYSTITIS 106 0.0089
761 ABDOMINAL PAIN UPPER 1824 0.0089
762 DRUG INEFFECTIVE 11621 0.0088
763 GASTROINTESTINAL HAEMORRHAGE 736 0.0088
764 PREMATURE BABY 261 0.0087
765 NODULE 112 0.0086
766 MIGRAINE 808 0.0085
767 VENTRICULAR TACHYCARDIA 139 0.0084
768 DEEP VEIN THROMBOSIS 546 0.0084
769 PAIN IN JAW 238 0.0084
770 MELAENA 182 0.0083
771 PARALYSIS 118 0.0082
772 IMMUNE SYSTEM DISORDER 108 0.0082
773 MEMORY IMPAIRMENT 1125 0.0082
774 BLINDNESS UNILATERAL 115 0.0081
775 VISUAL IMPAIRMENT 1000 0.0081
776 PLATELET COUNT INCREASED 105 0.0080
777 COLON CANCER 120 0.0080
778 APHASIA 243 0.0080
779 CARDIO-RESPIRATORY ARREST 332 0.0079
780 SKIN DISORDER 264 0.0079
781 PLATELET COUNT DECREASED 843 0.0079
782 EYE PAIN 444 0.0079
783 ASTHENIA 2953 0.0078
784 EJECTION FRACTION DECREASED 122 0.0078
785 EOSINOPHILIA 137 0.0078
786 HEPATIC STEATOSIS 145 0.0078
787 DYSPNOEA 4390 0.0077
788 QUALITY OF LIFE DECREASED 103 0.0077
789 ACNE 579 0.0076
790 NEOPLASM MALIGNANT 508 0.0076
791 RED BLOOD CELL COUNT DECREASED 217 0.0076
792 GASTROENTERITIS VIRAL 137 0.0076
793 DIABETES MELLITUS INADEQUATE CONTROL 134 0.0076
794 PRESYNCOPE 183 0.0075
795 ARTHRALGIA 3122 0.0075
796 SUBDURAL HAEMATOMA 107 0.0075
797 VISUAL ACUITY REDUCED 245 0.0074
798 RASH 3211 0.0074
799 HYPOTENSION 1476 0.0074
800 RHABDOMYOLYSIS 306 0.0073
801 UPPER GASTROINTESTINAL HAEMORRHAGE 123 0.0073
802 PRODUCT PRESCRIBING ERROR 174 0.0073
803 IMPAIRED QUALITY OF LIFE 105 0.0073
804 BACK DISORDER 118 0.0072
805 METASTASES TO LIVER 127 0.0072
806 BLOOD CREATINE PHOSPHOKINASE INCREASED 208 0.0072
807 ATRIAL FIBRILLATION 701 0.0072
808 PULMONARY EMBOLISM 672 0.0071
809 DYSPHAGIA 666 0.0070
810 HYPOPHAGIA 179 0.0070
811 INFLUENZA 775 0.0069
812 ISCHAEMIC STROKE 124 0.0069
813 DEHYDRATION 920 0.0069
814 PARAESTHESIA 1085 0.0069
815 DYSURIA 253 0.0069
816 MALAISE 3012 0.0069
817 ACUTE MYOCARDIAL INFARCTION 202 0.0068
818 HEART RATE DECREASED 240 0.0068
819 FEELING HOT 417 0.0068
820 BLOOD PRESSURE INCREASED 1026 0.0067
821 LOCALISED INFECTION 161 0.0067
822 HEADACHE 4154 0.0066
823 METASTASES TO BONE 108 0.0066
824 HYPOTHYROIDISM 209 0.0065
825 HEART RATE INCREASED 646 0.0065
826 INSOMNIA 1718 0.0064
827 ADVERSE EVENT 586 0.0064
828 GAIT DISTURBANCE 1209 0.0063
829 ANAPHYLACTIC REACTION 348 0.0063
830 NECK PAIN 346 0.0062
831 FATIGUE 4809 0.0062
832 CHILLS 724 0.0062
833 WHITE BLOOD CELL COUNT DECREASED 669 0.0062
834 HERNIA 119 0.0061
835 POOR QUALITY SLEEP 132 0.0061
836 DERMATITIS 128 0.0061
837 DEAFNESS 159 0.0061
838 DEPRESSED LEVEL OF CONSCIOUSNESS 240 0.0061
839 RENAL INJURY 180 0.0061
840 DEPRESSION 1378 0.0061
841 FOETAL EXPOSURE DURING PREGNANCY 492 0.0060
842 PRURITUS 2305 0.0060
843 NAUSEA 4737 0.0060
844 CORONARY ARTERY DISEASE 180 0.0059
845 MUSCLE SPASMS 1090 0.0059
846 SLEEP APNOEA SYNDROME 113 0.0059
847 ARRHYTHMIA 279 0.0059
848 SEIZURE 671 0.0058
849 FOOT FRACTURE 110 0.0058
850 PSYCHOTIC DISORDER 171 0.0058
851 HALLUCINATION, VISUAL 121 0.0057
852 SCAR 98 0.0057
853 PAIN IN EXTREMITY 1675 0.0057
854 EYE DISORDER 186 0.0057
855 ADVERSE DRUG REACTION 508 0.0057
856 DRUG ERUPTION 100 0.0056
857 TREMOR 935 0.0056
858 DYSARTHRIA 212 0.0056
859 BONE DISORDER 102 0.0056
860 CONJUNCTIVITIS 103 0.0055
861 URINARY RETENTION 185 0.0055
862 DISORIENTATION 217 0.0055
863 RIB FRACTURE 112 0.0054
864 FRACTURE 103 0.0054
865 INTESTINAL OBSTRUCTION 205 0.0054
866 HAEMORRHOIDS 106 0.0054
867 IMPAIRED WORK ABILITY 115 0.0054
868 THROAT IRRITATION 240 0.0053
869 ANXIETY 1522 0.0053
870 EPISTAXIS 398 0.0053
871 NEURALGIA 128 0.0053
872 BLOOD PRESSURE DECREASED 349 0.0052
873 OROPHARYNGEAL PAIN 485 0.0052
874 BLOOD POTASSIUM DECREASED 157 0.0052
875 HAEMORRHAGE 542 0.0052
876 PLASMA CELL MYELOMA 202 0.0052
877 CONVULSION 295 0.0052
878 THROMBOSIS 414 0.0051
879 MYALGIA 874 0.0051
880 UNDERDOSE 375 0.0051
881 LUNG NEOPLASM MALIGNANT 208 0.0051
882 NEUROPATHY PERIPHERAL 473 0.0050
883 RASH PRURITIC 268 0.0049
884 DIZZINESS 2460 0.0049
885 BLOOD PRESSURE ABNORMAL 98 0.0049
886 ORAL PAIN 110 0.0049
887 CHOLELITHIASIS 161 0.0049
888 PAIN 3013 0.0049
889 TINNITUS 224 0.0049
890 HAEMATOCHEZIA 268 0.0049
891 CARDIOVASCULAR DISORDER 123 0.0048
892 MENTAL DISORDER 210 0.0048
893 ABDOMINAL DISTENSION 491 0.0047
894 ANGIOEDEMA 208 0.0047
895 RHINORRHOEA 303 0.0047
896 LETHARGY 268 0.0047
897 SOMNOLENCE 935 0.0046
898 NO ADVERSE EVENT 834 0.0046
899 ABDOMINAL PAIN LOWER 115 0.0045
900 ANGINA PECTORIS 130 0.0045
901 LACTIC ACIDOSIS 144 0.0044
902 NEPHROLITHIASIS 200 0.0044
903 BRADYCARDIA 231 0.0044
904 RASH ERYTHEMATOUS 208 0.0043
905 DRY EYE 216 0.0043
906 SYNCOPE 425 0.0042
907 COGNITIVE DISORDER 196 0.0042
908 LIMB INJURY 114 0.0042
909 GASTRIC DISORDER 144 0.0042
910 NASAL CONGESTION 246 0.0042
911 BONE DENSITY DECREASED 131 0.0042
912 UNRESPONSIVE TO STIMULI 107 0.0041
913 SPEECH DISORDER 216 0.0041
914 PSORIASIS 534 0.0041
915 PALLOR 111 0.0041
916 NEUTROPHIL COUNT DECREASED 164 0.0040
917 DEATH 3392 0.0039
918 ILLNESS 402 0.0039
919 LOSS OF CONSCIOUSNESS 496 0.0039
920 THERAPEUTIC RESPONSE SHORTENED 127 0.0038
921 HIP FRACTURE 123 0.0038
922 HOSPITALISATION 586 0.0038
923 DYSPHONIA 222 0.0038
924 URINARY INCONTINENCE 112 0.0038
925 CEREBROVASCULAR ACCIDENT 636 0.0038
926 HYPOGLYCAEMIA 179 0.0037
927 CHEST DISCOMFORT 373 0.0036
928 BACK PAIN 841 0.0036
929 VERTIGO 218 0.0036
930 VISION BLURRED 487 0.0035
931 INTERNATIONAL NORMALISED RATIO INCREASED 99 0.0035
932 ACCIDENTAL OVERDOSE 127 0.0035
933 FALL 1153 0.0035
934 ERYTHEMA 703 0.0034
935 DRUG EFFECT INCOMPLETE 124 0.0034
936 CARDIAC FAILURE CONGESTIVE 272 0.0034
937 SURGERY 195 0.0033
938 DRUG EXPOSURE DURING PREGNANCY 113 0.0033
939 SWELLING FACE 216 0.0033
940 MOVEMENT DISORDER 105 0.0033
941 LIMB DISCOMFORT 100 0.0032
942 CARDIAC DISORDER 301 0.0032
943 POLLAKIURIA 134 0.0032
944 SKIN DISCOLOURATION 147 0.0032
945 INTENTIONAL PRODUCT MISUSE 276 0.0031
946 DISTURBANCE IN ATTENTION 167 0.0031
947 DEPRESSED MOOD 162 0.0031
948 ECZEMA 160 0.0031
949 AGITATION 223 0.0030
950 MYOCARDIAL INFARCTION 514 0.0029
951 PALPITATIONS 341 0.0029
952 TRANSIENT ISCHAEMIC ATTACK 98 0.0029
953 BLOOD GLUCOSE INCREASED 547 0.0029
954 THERAPY INTERRUPTED 207 0.0029
955 HALLUCINATION 216 0.0029
956 OVERDOSE 578 0.0027
957 THERAPY CESSATION 136 0.0026
958 BURNING SENSATION 184 0.0026
959 BALANCE DISORDER 220 0.0025
960 BONE PAIN 146 0.0025
961 SKIN EXFOLIATION 208 0.0025
962 INFLUENZA LIKE ILLNESS 202 0.0025
963 DYSKINESIA 99 0.0024
964 FLUSHING 239 0.0023
965 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 421 0.0023
966 CONSTIPATION 495 0.0023
967 UNEVALUABLE EVENT 165 0.0022
968 DERMATITIS ATOPIC 113 0.0021
969 HYPERHIDROSIS 272 0.0021
970 OCULAR HYPERAEMIA 100 0.0021
971 PROSTATE CANCER 166 0.0021
972 MALIGNANT NEOPLASM PROGRESSION 211 0.0021
973 PRODUCT DOSE OMISSION ISSUE 598 0.0020
974 FLATULENCE 114 0.0020
975 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 102 0.0020
976 FEELING ABNORMAL 461 0.0019
977 IRRITABILITY 115 0.0019
978 BREAST CANCER 172 0.0018
979 DYSGEUSIA 126 0.0017
980 SUICIDAL IDEATION 154 0.0017
981 HOT FLUSH 119 0.0016
982 PRODUCT QUALITY ISSUE 200 0.0015
983 EMOTIONAL DISTRESS 176 0.0015
984 DRY SKIN 187 0.0014
985 DRUG DOSE OMISSION 224 0.0014
986 INCORRECT DOSE ADMINISTERED 304 0.0013
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 190 0.0009
988 DRUG DEPENDENCE 125 0.0008
989 INJECTION SITE PAIN 187 0.0006